STING1 and metabolic dysfunction-associated steatohepatitis: Consistently, the catalytically inactive mutant of RNF13 failed to affect STING ubiquitination as well as its degradation (Fig. 8f, g), and exerted negligible impacts on NASH phenotypes (Fig. 8h–l).